National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

paclitaxel poliglumex
The agent paclitaxel linked to a biodegradable, water-soluble polyglutamate polymer with antineoplastic properties. The polyglutamate residue increases the water solubility of paclitaxel and allows delivery of higher doses than those achievable with paclitaxel alone. Paclitaxel promotes microtubule assembly and prevents microtubule depolymerization, thus interfering with normal mitosis. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:paclitaxel-polyglutamate polymer
polyglutamate paclitaxel
polyglutamic acid paclitaxel
Poly-L-Glutamic acid-Paclitaxel Conjugate
US brand name:Xyotax
Abbreviation:PG-TXL
Code name:CT-2103



Previous:oxycodone hydrochloride, OxyContin, p53 peptide vaccine, paclitaxel, paclitaxel albumin-stabilized nanoparticle formulation
Next:paclitaxel vitamin E-based emulsion formulation, paclitaxel-loaded polymeric micelle, padeliporfin, PADRE 965.10, PADRE-CMV fusion peptide vaccine

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov